In line with what was done in 2015, we continued our work on Hepatitis C and access to medicines in 2016. In May, we organised training to increase skills and knowledge on patent rights in Spain. The training session was taught by one of the major experts who oppose patents in Spain, Miguel Vidal Quadras.
At the same time, we worked with the civil society Hep C defending access to hepatitis C treatments. We met in Barcelona in the month of March with civil society organisations from Europe and America at a Hep C Coalition event to define strategies and narratives for the future and the International Liver Congress held in Barcelona in April.
In December, we were invited to participate in the Platform for those Affected by Hepatitis C (PLAFHC) Assembly in Madrid, where we shared a table along with other organisations and we presented and shared our work and views on the problem.
Moreover, we began producing a strategy during the narrative workshop in November in London along with the European Alliance for opposing the patent on sofosbuvir which will be presented in 2017.
At the same time, we worked with the civil society Hep C defending access to hepatitis C treatments. We met in Barcelona in the month of March with civil society organisations from Europe and America at a Hep C Coalition event to define strategies and narratives for the future and the International Liver Congress held in Barcelona in April.
In December, we were invited to participate in the Platform for those Affected by Hepatitis C (PLAFHC) Assembly in Madrid, where we shared a table along with other organisations and we presented and shared our work and views on the problem.
Moreover, we began producing a strategy during the narrative workshop in November in London along with the European Alliance for opposing the patent on sofosbuvir which will be presented in 2017.
OTRAS ACCIONES DE MOVILIZACIÓN E
INCIDENCIA SOBRE ACCESO E I+D
Panel de Alto Nivel de Naciones Unidas sobre Acceso a Medicamentos
|
Mesa-debate en la OMC
|
ENVI
|
TTIP leaks
|
Horizonte 2020
|
Jornadas de Acceso a Medicamentos UCM
|
Access to Medicines and Innovation
|
Alianza Europea por la investigación responsable y los medicamentos asequibles.
|
EACH Group
|
Grupo EPHA sobre Acceso a Medicamentos
|
Global Health Policy Forum
|
Hepatitis C
|